Search results
Justice Department is investigating McKinsey consulting firm’s role in opioid epidemic
CNN via Yahoo News· 4 hours agoThe Justice Department is investigating McKinsey & Company, one of the world’s largest consulting...
“Little Home Market”: The Connecticut Company Accused of Fueling an Execution Spree
The Intercept· 7 hours agoThe company is registered with Connecticut as a “manufacturer of drugs, cosmetics, and medical...
McKinsey advised drug companies on how to 'turbocharge' opioid sales. Now it's under criminal...
INSIDER via Yahoo News· 20 hours agoThe firm has previously paid nearly $1 billion to resolve lawsuits related to its opioid work. The...
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
BioPharma Dive via Yahoo Finance· 10 hours agoAstraZeneca’s London-traded shares rose 6% following the earnings announcement, changing hands at a...
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
Investor's Business Daily· 4 hours agoHowever, two out of three of Gilead's cancer drugs — cell therapy Tecartus and antibody drug...
Here’s why a Florida company recalled its male sexual enhancement drugs sold on Amazon
Miami Herald via Yahoo News· 11 hours ago“People with diabetes, high blood pressure, high cholesterol, or heart disease often...
Merck Beats on Earnings a Month After Major Drug Approval. The Stock Is Rising.
Barrons.com· 11 hours agoThe continued strength for Keytruda could give investors added comfort as the company prepares for...
Justice Department is investigating McKinsey consulting firm’s role in opioid epidemic | CNN...
CNN.com· 4 hours agoThe Justice Department is investigating McKinsey & Company, one of the world’s largest consulting...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 14 hours ago-thirds of the savings is expected to come out of Bristol Myers’ spending on research and...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 7 hours agoMeanwhile, Lilly locked up its acquisition of Point Biopharma, an expert in radioligand treatments...